# A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

> **NCT00004581** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 300 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Lopinavir/Ritonavir
- **DRUG:** Nevirapine

## Key facts

- **NCT ID:** NCT00004581
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 300 (—)
- **Last updated:** 2009-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004581, "A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00004581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*